Prospect Capital (PSEC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
9 Apr, 2026Executive summary
Seeking annual renewal of stockholder approval to issue common stock below net asset value (NAV), providing flexibility for capital raising.
Approval enhances access to low-cost financing and attractive investment opportunities, potentially increasing returns for both common and preferred stockholders.
Proposal is an option, not an obligation, and any issuance below NAV requires majority approval from independent directors.
Voting matters and shareholder proposals
Stockholders are asked to approve the option to issue common stock below NAV, a measure previously approved for 15 consecutive years.
Both ISS and Glass Lewis have consistently recommended voting in favor of this proposal.
Preferred stockholders vote alongside common stockholders on this proposal.
The special meeting to vote on this proposal is scheduled for June 9, 2026.
Board of directors and corporate governance
The board, including all independent directors, unanimously recommends approval, citing fiduciary duty to act in stockholders' best interests.
Management and employees own approximately 28% of the common stock, aligning their interests with stockholders.
Latest events from Prospect Capital
- Shareholders are called to vote on a major operating initiative at the June 2026 special meeting.PSEC
Proxy filing16 Apr 2026 - Proposal seeks renewed authority to sell common stock below NAV, with Board support and dilution risks.PSEC
Proxy Filing11 Mar 2026 - Shareholders are asked to approve limited sales of stock below net asset value for the next year.PSEC
Proxy Filing11 Mar 2026 - Robust middle-market lender with strong returns, low risk, and disciplined financial management.PSEC
Investor presentation2 Mar 2026 - Shareholders are asked to renew approval for below-NAV stock sales, capped at 25% per sale.PSEC
Proxy Filing27 Feb 2026 - Net investment income was $91M, NAV per share $6.21, and first lien loan exposure increased.PSEC
Q2 202610 Feb 2026 - Net investment income was $102.9M, NAV $8.74, and the 86th straight dividend was declared.PSEC
Q4 202422 Jan 2026 - Net investment income fell as NAV declined and the portfolio shifted to first-lien loans.PSEC
Q1 202515 Jan 2026 - Annual meeting adjourned to January 15, 2026, to solicit more votes on key proposals.PSEC
Proxy Filing8 Jan 2026